Select your timezone:

State-of-the-Art Session
Latest technologies and advances in the detection of allograft rejection and tissue injury status

Wednesday September 14, 2022 | 19:00 to 20:30

Learning Objectives

After this session, the attendees should be able to:
- Understand the overall diagnostic and prognostic performance of donor-derived cell free DNA (dd-cfDNA), nucleosomes, and extracellular vesicles (exosomes) in the determination of allograft injury and Rejection
- Understand the diagnostic and prognostic significance of the molecular microscope technique in transplanted patients
- Understand how artificial intelligence and digital pathology can be helpful to further improve our diagnosis in renal transplant biopsies


Carla C. Baan, Netherlands
Liquid biopsy in transplantation: ready for prime time

Dr. Ivy A. Rosales, United States
Spatial molecular profiling of kidney allograft biopsies

Dr. Jesper Kers, Netherlands
Artificial Intelligence algorithms: from "research use only" to everyday practice?

© 2022 TTS 2022